KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
Richman, Susan D, Seymour, Matthew T, Chambers, Philip, Elliott, Faye, Daly, Catherine L, Meade, Angela M, Taylor, Graham, Barrett, Jennifer H, Quirke, Philip
Published in Journal of clinical oncology (10.12.2009)
Published in Journal of clinical oncology (10.12.2009)
Get full text
Journal Article
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Maughan, Timothy S, Prof, Adams, Richard A, FRCP, Smith, Christopher G, BSc, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Idziaszczyk, Shelley, MPhil, Harris, Rebecca, MSc, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Mitchell, Jenna K, BHSc, Madi, Ayman, MRCP, Jasani, Bharat, Prof, James, Michelle D, BSc, Bridgewater, John, MD, Kennedy, M John, MD, Claes, Bart, MSc, Lambrechts, Diether, PhD, Kaplan, Richard, Prof, Cheadle, Jeremy P, Prof
Published in The Lancet (British edition) (18.06.2011)
Published in The Lancet (British edition) (18.06.2011)
Get full text
Journal Article
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Wasan, Harpreet, MD, Meade, Angela M, Dr, Adams, Richard, MD, Wilson, Richard, MD, Pugh, Cheryl, BSc, Fisher, David, MSc, Sydes, Benjamin, Madi, Ayman, MD, Sizer, Bruce, MB, Lowdell, Charles, FRCP, Middleton, Gary, MD, Butler, Rachel, BSc, Kaplan, Richard, Prof, Maughan, Tim, Prof
Published in The lancet oncology (01.05.2014)
Published in The lancet oncology (01.05.2014)
Get full text
Journal Article
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Adams, Richard A, FRCP, Meade, Angela M, DPhil, Seymour, Matthew T, Prof, Wilson, Richard H, MD, Madi, Ayman, MRCP, Fisher, David, MSc, Kenny, Sarah L, MSc, Kay, Edward, BA, Hodgkinson, Elizabeth, BPharm, Pope, Malcolm, Rogers, Penny, BSc, Wasan, Harpreet, FRCP, Falk, Stephen, MD, Gollins, Simon, DPhil, Hickish, Tamas, MD, Bessell, Eric M, PhD, Propper, David, MD, Kennedy, M John, MD, Kaplan, Richard, Prof, Maughan, Timothy S, Prof
Published in The lancet oncology (01.07.2011)
Published in The lancet oncology (01.07.2011)
Get full text
Journal Article
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
Seymour, Matthew T, Prof, Maughan, Timothy S, Prof, Ledermann, Jonathan A, Prof, Topham, Clare, MD, James, Roger, Prof, Gwyther, Stephen J, MBBS, Smith, David B, MD, Shepherd, Stephen, MD, Maraveyas, Anthony, PhD, Ferry, David R, Prof, Meade, Angela M, PhD, Thompson, Lindsay, MSc, Griffiths, Gareth O, MSc, Parmar, Mahesh KB, Prof, Stephens, Richard J
Published in The Lancet (British edition) (14.07.2007)
Published in The Lancet (British edition) (14.07.2007)
Get full text
Journal Article
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
Braun, Michael S, Richman, Susan D, Quirke, Philip, Daly, Catherine, Adlard, Julian W, Elliott, Faye, Barrett, Jennifer H, Selby, Peter, Meade, Angela M, Stephens, Richard J, Parmar, Mahesh K B, Seymour, Matthew T
Published in Journal of clinical oncology (01.06.2008)
Published in Journal of clinical oncology (01.06.2008)
Get full text
Journal Article
Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
BRAUN, Michael S, RICHMAN, Susan D, THOMPSON, Lindsay, DALY, Catherine L, MEADE, Angela M, ADLARD, Julian W, ALLAN, James M, PARMAR, Mahesh K. B, QUIRKE, Philip, SEYMOUR, Matthew T
Published in Journal of clinical oncology (20.11.2009)
Published in Journal of clinical oncology (20.11.2009)
Get full text
Journal Article
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial
Bird, Sheila M, Strang, John, Ashby, Deborah, Podmore, John, Robertson, J. Roy, Welch, Sarah, Meade, Angela M, Parmar, Mahesh K.B
Published in Contemporary clinical trials communications (01.03.2017)
Published in Contemporary clinical trials communications (01.03.2017)
Get full text
Journal Article
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
Raimondi, Alessandra, Nichetti, Federico, Stahler, Arndt, Wasan, Harpreet S., Aranda, Enrique, Randon, Giovanni, Kurreck, Annika, Meade, Angela M., Díaz-Rubio, Eduardo, Niger, Monica, Stintzing, Sebastian, Palermo, Federica, Trarbach, Tanja, Prisciandaro, Michele, Sommerhäuser, Greta, Fisher, David, Morano, Federica, Pietrantonio, Filippo, Modest, Dominik P.
Published in European journal of cancer (1990) (01.09.2023)
Published in European journal of cancer (1990) (01.09.2023)
Get full text
Journal Article
Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy
Madi, Ayman, Fisher, David, Maughan, Timothy S., Colley, James P., Meade, Angela M., Maynard, Julie, Humphreys, Vikki, Wasan, Harpreet, Adams, Richard A., Idziaszczyk, Shelley, Harris, Rebecca, Kaplan, Richard S., Cheadle, Jeremy P.
Published in European journal of cancer (1990) (01.10.2018)
Published in European journal of cancer (1990) (01.10.2018)
Get full text
Journal Article
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
Vale, Claire L, Tierney, Jayne F, Fisher, David, Adams, Richard A, Kaplan, Richard, Maughan, Timothy S, Parmar, Mahesh K.B, Meade, Angela M
Published in Cancer treatment reviews (01.10.2012)
Published in Cancer treatment reviews (01.10.2012)
Get full text
Journal Article
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer
Kwakman, Johannes J. M., van Kruijsdijk, Rob C. M., Elias, Sjoerd G., Seymour, Matthew T., Meade, Angela M., Visseren, Frank L. J., Punt, Cornelis J. A., Koopman, Miriam
Published in Acta oncologica (04.03.2019)
Published in Acta oncologica (04.03.2019)
Get full text
Journal Article
Comprehensive pharmacogenetic profiling of the epidermal growth factor receptor pathway for biomarkers of response to, and toxicity from, cetuximab
Madi, Ayman, Fisher, David, Maughan, Timothy S, Colley, James P, Meade, Angela M, Tejpar, Sabine, Van den Bosch, Ben, Maynard, Julie, Humphreys, Vikki, Wasan, Harpreet, Adams, Richard A, Idziaszczyk, Shelley, Harris, Rebecca, Kaplan, Richard S, Cheadle, Jeremy P
Published in Journal of medical genetics (01.08.2017)
Published in Journal of medical genetics (01.08.2017)
Get full text
Journal Article
Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths: N-ALIVE to prevent opioid deaths post-release
Parmar, Mahesh K. B., Strang, John, Choo, Louise, Meade, Angela M., Bird, Sheila M.
Published in Addiction (Abingdon, England) (01.03.2017)
Published in Addiction (Abingdon, England) (01.03.2017)
Get full text
Journal Article
MRC SORCE trial: Analysis of patients' presenting characteristics, tumor staging, and surgical approach
Ritchie, Alastair W. S., Meade, Angela M., Choo, Louise, Smith, Ben, Welland, Andrew, Gregory, Adam, Kaplan, Richard S., Eisen, Tim
Published in Journal of clinical oncology (01.02.2014)
Published in Journal of clinical oncology (01.02.2014)
Get full text
Journal Article
Patients' preferences for adjuvant sorafenib after resection of intermediate or high-risk renal cell carcinoma in the SORCE trial: What makes it worthwhile?
Blinman, Prunella Louise, Davis, Ian D., Martin, Andrew, Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth J., Coskinas, Xanthi, Kaplan, Richard S., Ritchie, Alastair W. S., Meade, Angela M., Eisen, Tim, Stockler, Martin R.
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients withKRASwild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Wasan, Harpreet, Meade, Angela M, Adams, Richard, Wilson, Richard, Pugh, Cheryl, Fisher, David, Sydes, Benjamin, Madi, Ayman, Sizer, Bruce, Lowdell, Charles, Middleton, Gary, Butler, Rachel, Kaplan, Richard, Maughan, Tim
Published in The lancet oncology (01.05.2014)
Published in The lancet oncology (01.05.2014)
Get full text
Journal Article